WUHAN NEUROPHTH BIOLOGICAL TECH LIMITED COMPANY has a total of 12 patent applications. Its first patent ever was published in 2018. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are VLP BIOTECH INC, JIVANA BIOTECHNOLOGY INC and INTROGEN THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | Canada | 1 | |
#3 | China | 1 | |
#4 | Singapore | 1 | |
#5 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Agriculture | |
#5 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Enzymes | |
#6 | Animal care | |
#7 | Measuring microorganism processes | |
#8 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Li Bin | 12 |
Publication | Filing date | Title |
---|---|---|
WO2020038473A1 | Recombinant human type ii mitochondrial dynein-like gtpase gene sequence and application thereof | |
WO2020038352A1 | Compositions and methods for treating leber's hereditary optic neuropathy | |
CA3109432A1 | Compositions and methods for treating leber's hereditary optic neuropathy | |
WO2020001657A1 | Compositions and methods for treating leber's hereditary optic neuropathy | |
CN110876269A | Compositions and methods for treating hereditary optic neuropathy | |
SG11202012044QA | Compositions and methods for treating leber's hereditary optic neuropathy | |
WO2020000641A1 | Nucleic acid for coding human nadh dehydrogenase sigmasubunit protein and application thereof | |
WO2020010491A1 | Nucleic acid for encoding human nadh dehydrogenase subunit 4 protein and application thereof |